FDA spells out details of corrective DTC advertising study

01/8/2013

The FDA’s study of corrective direct-to-consumer (DTC) advertising will include 6,650 interviews of randomly assigned participants and include messaging about asthma in the first phase and weight-loss products in the second phase, according to a recent Federal Register notice covering the study’s information collection requirements. The agency is conducting the study to forward the development of empirical literature regarding the influences of corrective advertising. John Kamp, Executive Director, Coalition for Healthcare Communication, commented that this type of advertising “is an extraordinary remedy” that should be applied only to “violations that are extraordinary.” Read more.

View Full Article in:

http://www.cohealthcom.org/2013/01/03/fda-responds-to-comments-on-proposed-corre...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT